Press Releases

Press Releases

    Date Title View
    04/04/19
    Summary ToggleHorizon Pharma plc Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    PDF Version
    03/18/19
    Summary ToggleHorizon Pharma plc Wins PR News CSR Award for Partnership with Perspectives Math and Science Academy
    PDF Version
    03/11/19
    Summary ToggleHorizon Pharma plc Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
    PDF Version
    03/06/19
    Summary ToggleHorizon Pharma plc Announces Pricing of Public Offering of Ordinary Shares
    PDF Version
    03/04/19
    Summary ToggleHorizon Pharma plc Announces Proposed Public Offering of Ordinary Shares
    PDF Version
    03/01/19
    Summary ToggleHorizon Pharma plc Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    PDF Version
    02/28/19
    Summary ToggleHorizon Pharma plc Announces Phase 3 Confirmatory Trial Evaluating Teprotumumab (OPTIC) for the Treatment of Active Thyroid Eye Disease (TED) Met Primary and All Secondary Endpoints
    PDF Version
    02/27/19
    Summary ToggleHorizon Pharma plc Reports Record Fourth-Quarter and Full-Year 2018 Net Sales Driven by Orphan and Rheumatology Segment; Announces Full-Year 2019 Guidance
    02/25/19
    Summary ToggleHorizon Pharma plc to Participate in Cowen and Company 39th Annual Health Care Conference
    PDF Version
    01/29/19
    Summary ToggleHorizon Pharma plc to Release Fourth-Quarter and Full-Year 2018 Financial Results and Host Webcast on Feb. 27, 2019
    PDF Version
    Displaying 21 - 30 of 446 results